Beta-lactam antibiotic-containing tablet and production thereof
Abstract
This invention provides β-lactam antibiotic-containing tablets capable of being orally taken either as such owing to their being small-sized, hence still easily swallowable, or, in the case of administration to the aged encountering some difficulty in swallowing, in the form of dispersions resulting from easy self-disintegration upon being dropped into water in a glass as well as a method of producing the same. The tablets of this invention comprise, on the per-tablet basis, 60-85% by weight of a β-lactam antibiotic, 1-10% by weight of low-substituted hydroxypropylcellulose and/or crosslinked polyvinylpyrrolidone as a disintegrator, and 0.5-2% by weight of a binder. Granules to be compressed for tableting are prepared using water or an aqueous solution of ethanol or the like.
Claims
exact text as granted — not AI-modified1 - 10 . (canceled)
11 . A self-disintegrating tablet comprising a sweetener consisting essentially of:
crystalline grains consisting of saccharin, a saccharin salt, cyclamic acid, or a cyclamic acid salt which have a mean particle size of not less than 150 μm, or granules consisting essentially of saccharin, a saccharin salt, cyclamic acid, or a cyclamic acid salt and light anhydrous silicic acid or hydrated silicon dioxide; wherein said self-disintegrating tablet when placed in a glass of water spontaneously collapses into a dispersion.
12 . The tablet of claim 11 , which comprises granules consisting essentially of saccharin, a saccharin salt, cyclamic acid, or a cyclamic acid salt and light anhydrous silicic acid or hydrated silicon dioxide produced by wet granulation.
13 . The tablet of claim 11 , which comprises granules consisting essentially of saccharin, a saccharin salt, cyclamic acid, or a cyclamic acid salt and light anhydrous silicic acid or hydrated silicon dioxide produced by dry granulation.
14 . The tablet of claim 11 , which when placed in a glass of water spontaneously collapses into a dispersion within about three minutes.
15 . The tablet of claim 11 , further comprising at least one binder, additive or excipient.
16 . The tablet of claim 11 , further comprising a disintegrator in an amount ranging from 1 to 10% by weight.
17 . The tablet of claim 11 , which contains:
0.5 to 2% by weight of a binder, 0.5 to 15% by weight of a sweetener consisting of grains of an artificial sweetener having a mean particle size of not less than 150 μm selected from the group consisting of saccharin, a saccharin salt, cyclamic acid or a cyclamic acid salt; or 0.5 to 15% by weight of a sweetener consisting of granulated mixture of light anhydrous silicic acid or hydrated silicon dioxide, and an artificial sweetener selected from the group consisting of saccharin, a saccharin salt, cyclamic acid or a cyclamic acid salt; and 1-10% by weight of a salt-type disintegrator or a non-ionic disintegrator; wherein said self-disintegrating tablet when placed in a glass of water spontaneously collapses into a dispersion.
18 . The tablet of claim 11 , wherein said sweetener consists of crystalline grains of saccharin.
19 . The tablet of claim 11 , wherein said sweetener consists of crystalline grains of a saccharin salt.
20 . The tablet of claim 11 , wherein said sweetener consists of crystalline grains of saccharin calcium.
21 . The tablet of claim 11 , wherein said sweetener consists of crystalline grains of saccharin sodium.
22 . The tablet of claim 11 , wherein said sweetener consists of crystalline grains of cyclamic acid.
23 . The tablet of claim 11 , wherein said sweetener consists of crystalline grains of a cyclamic acid salt.
24 . The tablet of claim 11 wherein said sweetener consists of crystalline grains of sodium cyclamate, calcium cyclamate or ammonium cyclamate.
25 . The tablet of claim 11 , wherein said sweetener consists of granules that are produced by granulation of a mixture of light anhydrous silicic acid or hydrated silicon dioxide, and an artificial sweetener selected from the group consisting of saccharin, a saccharin salt, cyclamic acid or a cyclamic acid salt; using a solution of ethanol or isopropyl alcohol, or an aqueous solution of ethanol or isopropyl alcohol which contains 3-99% (v/v) ethanol or isopropyl alcohol.
26 . A self-disintegrating tablet consisting essentially of:
60 to 85% by weight of a β-lactam antibiotic, 0.5 to 2% by weight of a binder, 0.5 to 15% by weight of a sweetener consisting of an artificial sweetener having a mean particle size of not less than 150 μm selected from the group consisting of saccharin, a saccharin salt, cyclamic acid or a cyclamic acid salt; or 0.5 to 15% by weight of a granulated mixture of light anhydrous silicic acid or hydrated silicon dioxide, and an artificial sweetener selected from the group consisting of saccharin, a saccharin salt, cyclamic acid or a cyclamic acid salt; and optionally, 1-10% by weight of a salt-type disintegrator or a non-ionic disintegrator; wherein said self-disintegrating tablet when placed in a glass of water spontaneously collapses into a dispersion.
27 . A granulated synthetic sweetener which comprises:
a synthetic sweetener selected from the group consisting of saccharin, a saccharin salt, cyclamic acid, and a cyclamic acid salt; and light anhydrous silicic acid or hydrated silicon dioxide, or both.
28 . The granulated synthetic sweetener of claim 27 , which comprises 1 to 30% anhydrous silicic acid by weight of the synthetic sweetener.
29 . The granulated synthetic sweetener of claim 27 , which comprises 1 to 30% hydrated silicon dioxide by weight of the synthetic sweetener.
30 . The granulated synthetic sweetener of claim 27 , further comprising one or more binders, excipients or additives.Join the waitlist — get patent alerts
Track US2007134325A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.